PUBLISHER: The Business Research Company | PRODUCT CODE: 1948204
PUBLISHER: The Business Research Company | PRODUCT CODE: 1948204
Sinus tissue resection devices are specialized medical tools designed to help remove diseased or obstructive tissue from the sinus cavities. They are crafted to offer precision and control during tissue removal, allowing healthcare professionals to accurately target and excise problematic tissue while minimizing harm to surrounding areas.
The main types of sinus tissue resection devices include powered instruments, handheld instruments, endoscopic instruments, and others. Powered instruments in sinus tissue resection devices are electrically or pneumatically operated surgical tools made to precisely cut, remove, or debride soft or hard tissue during sinus operations, improving surgical accuracy and efficiency. These devices are distributed through various channels, such as direct sales, distributors, online retailers, hospital procurement departments, and specialized medical supply companies. Their applications include sinus surgery, nasal polypectomy, treatment of chronic sinusitis, septoplasty, among others. They are used by end-users like hospitals, specialty clinics, ambulatory surgical centers, and more.
Tariffs have influenced the sinus tissue resection devices market by increasing the cost of imported precision instruments and endoscopic systems. Segments such as powered microdebriders, navigation systems, and laser-assisted devices are most affected, particularly in regions like Asia-Pacific including China and India. These tariffs have led to higher production and procurement costs, affecting hospital and clinic budgets. On the positive side, tariffs have encouraged local manufacturing, innovation in device design, and adoption of domestically produced alternatives, strengthening regional supply chains.
The sinus tissue resection devices market research report is one of a series of new reports from The Business Research Company that provides sinus tissue resection devices market statistics, including sinus tissue resection devices industry global market size, regional shares, competitors with a sinus tissue resection devices market share, detailed sinus tissue resection devices market segments, market trends and opportunities, and any further data you may need to thrive in the sinus tissue resection devices industry. This sinus tissue resection devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The sinus tissue resection devices market size has grown strongly in recent years. It will grow from $1.19 billion in 2025 to $1.29 billion in 2026 at a compound annual growth rate (CAGR) of 8.4%. The growth in the historic period can be attributed to reliance on conventional handheld instruments, limited endoscopic adoption in early years, growth of hospitals and specialty clinics, increasing prevalence of chronic sinusitis, conventional navigation and laser systems availability.
The sinus tissue resection devices market size is expected to see strong growth in the next few years. It will grow to $1.77 billion in 2030 at a compound annual growth rate (CAGR) of 8.1%. The growth in the forecast period can be attributed to technological advancements in powered microdebriders, rising integration of navigation and laser systems, increasing outpatient and ambulatory procedures, expansion of ENT specialty clinics, regulatory compliance and enhanced safety standards. Major trends in the forecast period include rising adoption of powered instruments in sinus surgery, increasing use of endoscopic techniques for nasal procedures, growing demand for minimally invasive surgical solutions, expansion of ambulatory surgical centers and specialty clinics, enhanced focus on precision and safety in tissue resection.
The rising prevalence of chronic sinusitis is expected to significantly contribute to the growth of the sinus tissue resection devices market. Chronic sinusitis, characterized by inflammation of the sinuses lasting over 12 weeks, causes symptoms like nasal congestion, facial pain, and diminished sense of smell. This increase in cases is largely due to environmental allergens such as pollen and pollution, which trigger inflammation and hinder complete recovery, resulting in prolonged sinus infections. Sinus tissue resection devices help by precisely removing obstructive tissue, improving sinus drainage, reducing inflammation, and alleviating symptoms while preventing recurring infections. For example, in December 2023, TGH Urgent Care powered by Fast Track reported that nearly 29 million adults in the United States, or 11.6% of the adult population, suffered from sinusitis, making it a common cause for physician visits. Hence, the growing incidence of chronic sinusitis is expected to drive market growth.
Leading companies in the sinus tissue resection devices market are developing innovative solutions such as single-use ENT instruments to improve procedural efficiency and accessibility in ENT care with portable, minimally invasive surgical tools. Single-use ear, nose, and throat instruments are sterile, disposable tools designed for one-time use during diagnostic or surgical procedures, ensuring patient safety, minimizing infection risks, and removing the need for reprocessing. For instance, in March 2024, Olympus Canada launched the CELERIS Single-Use Sinus Debrider and Celon Elite, including the Celon ProBreath, thereby expanding its ENT product range. The CELERIS system's unique single-use design includes features like a bendable tip that enhances precision and reduces the need to switch instruments during procedures. This launch offers healthcare providers an efficient and cost-effective option for treating common ENT conditions, such as sinusitis, especially in outpatient settings without requiring costly operating room resources.
In April 2024, Integra LifeSciences, a US-based medical technology company, acquired Acclarent, Inc. for an undisclosed sum. With this acquisition, Integra LifeSciences seeks to broaden its ENT product offerings, enhance its market presence, and drive faster growth within the promising ENT device segment. Acclarent, Inc. is a US-based manufacturer that delivers innovative surgical devices and solutions for ear, nose, and throat (ENT) procedures.
Major companies operating in the sinus tissue resection devices market are Johnson And Johnson, Medtronic Plc, Stryker Corporation, B Braun Melsungen AG, Olympus Corporation, Smith And Nephew plc, Cook Medical, Karl Storz GmbH And Co KG, Integra LifeSciences Holdings Corporation, Meril Life Sciences Pvt Ltd, Summit Medical Inc, PENTAX Medical, STILLE AB, Entellus Medical Inc, ClaroNav Kolahi Inc, Millennium Surgical Corp, Sinusys Corporation, Spiggle And Theis Medizintechnik GmbH, Beijing VCA Laser Technology Co Ltd, Medicon eG, Heinz Kurz GmbH Medizintechnik, Rudolf Medical GmbH
North America was the largest region in the sinus tissue resection devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sinus tissue resection devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the sinus tissue resection devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The sinus tissue resection devices market consists of sales of products such as surgical shavers, sinus dilation devices, sinus irrigation systems, surgical knives, and tissue ablation devices. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Sinus Tissue Resection Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses sinus tissue resection devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for sinus tissue resection devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The sinus tissue resection devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.